P-D-R Pharma Documentation Ring

The P-D-R is an association whose members represent the scientific information departments of the leading international R&D-based pharmaceutical corporations.

Latest News from the P-D-R Company Websites

Published 15 February 2019 | 6:09 pm

UCB builds on its R&D footprint to form a research satellite facility within King's College London

UCB builds on its strategy of enhancing capabilities by establishing satellite research facilities in innovative environments, embedding company scientists within global centres more ...

Published 15 February 2019 | 3:54 pm

Learn How Scientists are Fighting for Cures

Every day, researchers, developers, and innovators in the pharmaceutical industry are working to discover cures for some of the world's most complex diseases. Our scientists more ...

Published 15 February 2019 | 3:28 pm

Lilly Completes Acquisition of Loxo Oncology

INDIANAPOLIS, Feb. 15, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) today announced the successful completion of its acquisition of Loxo Oncology, Inc. more ...

Published 15 February 2019 | 8:30 am

Shire's Full Year 2018 Results

- 2018 product sales growth +3.9% and $4.6 billion operating cash flow - Solid growth contributions in 2018 from Immunology, recently-launched products, international more ...

Published 15 February 2019 | 8:09 am

Notice Regarding Issue of Hybrid Bonds to replace Senior Short Term Loan (Offering of Subordinated Bonds)

OSAKA, JAPAN, February 15, 2019 - Takeda Pharmaceutical Company Limited ( TSE:4502/NYSE:TAK ) ("Takeda") today announced that it filed with the Director of the Kanto more ...

Published 14 February 2019 | 10:38 pm

Lilly To Participate in Leerink Partners Global Healthcare Conference

INDIANAPOLIS, Feb. 14, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in the Leerink Partners Global Healthcare Conference on Wednesday, February more ...

Published 14 February 2019 | 12:33 pm

Boehringer Ingelheim and Lilly announce the CAROLINA® cardiovascular outcome trial of Tradjenta® met its primary endpoint of non-inferiority compared with glimepiride

- Tradjenta (linagliptin) demonstrated no increased cardiovascular risk compared with glimepiride in adults with type 2 diabetes and cardiovascular risk - With a median more ...

Published 14 February 2019 | 10:58 am

Emotions matter - let's listen

Posted by Bharat Tewarie, Executive Vice President & Chief Marketing Officer 14-Feb-2019 more ...

Published 14 February 2019 | 8:05 am

Full-Year 2018 Results

Pascal Soriot, Chief Executive Officer, commenting on the results said: more ...

Published 13 February 2019 | 10:56 pm

Novartis receives FDA approval for Egaten® for the treatment of fascioliasis, a neglected tropical disease

Egaten is the only drug approved in the US for the treatment of people with fascioliasis and is currently the only treatment recommended by the WHO more ...

Pharma Documentation Ring:
26 companies - 4 common aims:

  • Promote exchange of experience/networking among members
  • Encourage commercial development of new information services and systems
  • Jointly assess new and existing products and services
  • Provide a forum for the information industry
  • How to become a P-D-R member?
Next Annual General Meeting, Vienna, September 25 – 28, 2018

Next Annual General Meeting, Vienna, September 25 – 28, 2018